Host specificity of bacterial pathogens

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 12, 2013, Pages

  Baumler, Andreas ^a   Fang, Ferric C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLOSIS; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL DIVISION; ECOLOGICAL SPECIALIZATION; GENE REARRANGEMENT; HORIZONTAL GENE TRANSFER; HOST RANGE; HUMAN; MICROBIAL COMMUNITY; MOLECULAR PATHOLOGY; MOUSE MODEL; MULTIFACTORIAL INHERITANCE; NONHUMAN; PATHOGENESIS; SALMONELLA ENTERICA; SEROTYPE; YERSINIA; ANIMAL; BACTERIAL GENOME; BIOLOGICAL MODEL; CELL CULTURE; EVOLUTION; GENETIC RECOMBINATION; HOST PATHOGEN INTERACTION; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; REVIEW; VIRULENCE; YERSINIA ENTEROCOLITICA;

COMPLEMENT; IRON;

ANIMALS; BACTERIAL ADHESION; BIOLOGICAL EVOLUTION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; GENOME, BACTERIAL; HOST SPECIFICITY; HOST-PATHOGEN INTERACTIONS; IRON; MICE; MODELS, BIOLOGICAL; RECOMBINATION, GENETIC; SALMONELLA ENTERICA; VIRULENCE; YERSINIA ENTEROCOLITICA;

EID: 84889004626     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a010041     Document Type: Article

References (166)

1. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. 1999. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci 96: 14043-14048.
2. Altmeyer RM, McNern JK, Bossio JC, Rosenshine I, Finlay BB, Galan JE. 1993. Cloning and molecular characterization of a gene involved in Salmonella adherence and invasion of cultured epithelial cells. Mol Microbiol 7: 89-98.
3. Anderson RM, May RM. 1982. Coevolution of hosts and parasites. Parasitology 85: 411-426.
4. Ayhan A, Gokoz A, Karacadag S, Telatar H. 1973. The liver in typhoid fever. Am J Gastroenterol 59: 141-146.
5. Barrow PA, Huggins MB, Lovell MA. 1994. Host specificity of Salmonella infection in chickens and mice is expressed in vivo primarily at the level of the reticuloendothelial system. Infect Immun 62: 4602-4610.
6. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
7. Bäumler AJ, Tsolis RM, Ficht TA, Adams LG. 1998. Evolution of host adaptation in Salmonella enterica. Infect Immun 66: 4579-4587.
8. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R. 2005. Dengue fever in humanized NOD/SCID mice. J Virol 79: 13797-13799.
9. Berges BK, Rowan MR. 2011. The utility of the new generation of humanized mice to study HIV-1 infection: Transmission, prevention, pathogenesis, and treatment. Retrovirology 8: 65.
10. Bernard D, Peakman M, Hayday AC. 2008. Establishing humanized mice using stem cells: Maximizing the potential. Clin Exp Immunol 152: 406-414.
11. Betancor L, Yim L, Martínez A, Fookes M, Sasias S, Schelotto F, Thomson N, Maskell D, Chabalgoity JA. 2012. Genomic comparison of the closely related Salmonella enterica serovars Enteritidis and Dublin. Open Microbiol J 6: 5-13.
12. Bharadwaj S, Anim JT, Ebrahim F, Aldahham A. 2009. Granulomatous inflammatory response in a case of typhoid fever. Med Princ Pract 18: 239-241.
13. Bohnhoff M, Miller CP. 1962. Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J Infect Dis 111: 117-127.
14. Bos KI, Schuenemann VJ, Golding GB, Burbano HA, Waglechner N, Coombes BK, McPhee JB, DeWitte SN, Meyer M, Schmedes S, et al. 2011. A draft genome of Yersinia pestis from victims of the Black Death. Nature 478: 506-510.
15. Brehm MA, Shultz LD, Greiner DL. 2010. Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17: 120-125.
16. Butler T, Ho M, Acharya G, Tiwari M, Gallati H. 1993. Interleukin-6, g interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 37: 2418-2421.
17. Campo N, Dias MJ, Daveran-Mingot ML, Ritzenthaler P, Le Bourgeois P. 2004. Chromosomal constraints in Grampositive bacteria revealed by artificial inversions. Mol Microbiol 51: 511-522.
18. Chadfield MS, Brown DJ, Aabo S, Christensen JP, Olsen JE. 2003. Comparison of intestinal invasion and macrophage response of Salmonella Gallinarum and other hostadapted Salmonella enterica serovars in the avian host. Vet Microbiol 92: 49-64.
19. Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, et al. 2004. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci 101: 13826-13831.
20. Chen PE, Cook C, Stewart AC, Nagarajan N, Sommer DD, Pop M, Thomason B, Kiley Thomason MP, Lentz S, Nolan N, et al. 2010. Genomic characterization of the Yersinia genus. Genome Biol 11: R1.
21. Cheney CP, Schad PA, Formal SB, Boedeker EC. 1980. Species specificity of in vitro Escherichia coli adherence to host intestinal cell membranes and its correlation with in vivo colonization and infectivity. Infect Immun 28: 1019-1027.
22. Chiu CH, Tang P, Chu C, Hu S, Bao Q, Yu J, Chou YY, Wang HS, Lee YS. 2005. The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res 33: 1690-1698.
23. Collins FM, Carter PB. 1978. Growth of salmonellae in orally infected germfree mice. Infect Immun 21: 41-47.
24. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, et al. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435-1438.
25. den Bakker HC, Moreno Switt AI, Govoni G, Cummings CA, Ranieri ML, Degoricija L, Hoelzer K, Rodriguez-Rivera LD, Brown S, Bolchakova E, et al. 2011. Genome sequencing reveals diversification of virulence factor content and possible host adaptation in distinct subpopulations of Salmonella enterica. BMC Genomics 12: 425.
26. Dineen JK. 1963. Immunological aspects of parasitism. Nature 197: 268-269.
27. Disson O, Grayo S, Huillet E, Nikitas G, Langa-Vives F, Dussurget O, Ragon M, Le Monnier A, Babinet C, Cossart P, et al. 2008. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature 455: 1114-1118.
28. Dorsey CW, Laarakker MC, Humphries AD, Weening EH, Bäumler AJ. 2005. Salmonella enterica serotype Typhimurium MisL is an intestinal colonization factor that binds fibronectin. Mol Microbiol 57: 196-211.
29. Elsinghorst EA, Baron LS, Kopecko DJ. 1989. Penetration of human intestinal epithelial cells by Salmonella: Molecular cloning and expression of Salmonella typhi invasion determinants in Escherichia coli. Proc Natl Acad Sci 86: 5173-5177.
30. Everett J, Lea SM, Caesar JJE, Johnson S, Tang CM. 2011. Investigating host specificity of Neisseria meningitidis. Mol Immunol 48: 1673.
31. Fang FC, Bäumler AJ. 2012. A tollgate for typhoid. Cell 151: 473-475.
32. Fang FC, Fierer J. 1991. Human infection with Salmonella dublin. Medicine 70: 198-207.
33. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. 2012. Invasive non-typhoidal Salmonella disease: An emerging and neglected tropical disease in Africa. Lancet 379: 2489-2499.
34. Firoz Mian M, Pek EA, Chenoweth MJ, Ashkar AA. 2011. Humanized mice are susceptible to Salmonella typhi infection. Cell Mol Immunol 8: 83-87.
35. Fischl MA, Dickinson GM, Sinave C, Pitchenik AE, Cleary TJ. 1986. Salmonella bacteremia as manifestation of aquired immunodeficiency syndrome. Arch Intern Med 146: 113-115.
36. Flor HH. 1971. Current status of the gene-for-gene concept. Ann Rev Phytopathol 9: 275-296.
37. Forest CG, Ferraro E, Sabbagh SC, Daigle F. 2010. Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology 156: 3689-3698.
38. Fredriksson-Ahomaa M. 2009. Epidemiology of human Yersinia pseudotuberculosis infection. Archiv Fur Lebensmittelhygiene 60: 82-87.
39. Frey J. 2011. The role of RTX toxins in host specificity of animal pathogenic Pasteurellaceae. Vet Microbiol 153: 51-58.
40. Galán JE, Curtiss R III. 1989. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci 86: 6383-6387.
41. Garnick E. 1992. Parasite virulence and parasite-host coevolution: A reappraisal. J Parasitol 78: 381-386.
42. Glynn JR, Palmer SR. 1992. Incubation period, severity of disease, and infecting dose: Evidence from a Salmonella outbreak. Am J Epidemiol 136: 1369-1377.
43. Gordon MA. 2008. Salmonella infections in immunocompromised adults. J Infect 56: 413-422.
44. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME. 2002. Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: High mortality and frequent recrudescence. AIDS 16: 1633-1641.
45. Granoff DM, Welsch JA, Ram S. 2009. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun 77: 764-769.
46. Haneda T, Winter SE, Butler BP, Wilson RP, Tukel C, Winter MG, Godinez I, Tsolis RM, Bäumler AJ. 2009. The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism. Infect Immun 77: 2932-2942.
47. Hashimoto Y, Khan AQ. 1997. Comparison of ViaB regions of Vi-positive organisms. FEMS Microbiol Lett 157: 55-57.
48. Helm RA, Porwollik S, Stanley AE, Maloy S, McClelland M, Rabsch W, Eisenstark A. 2004. Pigeon-associated strains of Salmonella enterica serovar Typhimurium phage type DT2 have genomic rearrangements at rRNA operons. Infect Immun 72: 7338-7341.
49. {thorn} TCR-ab cells and IFN-g in bacterial clearance independent of intracellular location. J Immunol 156: 3321-3326.
50. Hill CW, Gray JA. 1988. Effects of chromosomal inversion on cell fitness in Escherichia coli K-12. Genetics 119: 771-778.
51. Hinnebusch BJ, Rudolph AE, Cherepanov P, Dixon JE, Schwan TG, Forsberg A. 2002. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 296: 733-735.
52. Hodak H, Galán JE. 2013. A Salmonella Typhi homologue of bacteriophage muramidases controls typhoid toxin secretion. EMBO Rep 14: 95-102.
53. Hone DM, Harris AM, Chatfield S, Dougan G, Levine MM. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9: 810-816.
54. Hughes LE, Gibson EA, Roberts HE, Davies ET, Davies G, Sojka WJ. 1971. Bovine salmonellosis in England and Wales. Br Vet J 127: 225-238.
55. Ishibashi Y, Arai T. 1996. A possible mechanism for hostspecific pathogenesis of Salmonella serovars. Microb Pathog 21: 435-446.
56. null mice engrafted with human erythrocytes. Antimicrob Agents Chemother 53: 4533-4536.
57. Kapperud G. 1991. Yersinia enterocolitica in food hygiene. Int J Food Microbiol 12: 53-65.
58. Kelterborn E. 1967. Salmonella-species. First isolations, names and occurrence. Springer-Verlag, New York.
59. Keuter M, Dharmana E, Gasem MH, van Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WM, Demacker P, Sauerwein R, Gallati H, van der Meer JW. 1994. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169: 1306-1311.
60. Khelef N, Lecuit M, Bierne H, Cossart P. 2006. Species specificity of the Listeria monocytogenes InlB protein. Cell Microbiol 8: 457-470.
61. Kingsley RA, van Amsterdam K, Kramer N, Bäumler AJ. 2000. The shdA gene is restricted to serotypes of Salmonella enterica subspecies I and contributes to efficient and prolonged fecal shedding. Infect Immun 68: 2720-2727.
62. Kingsley RA, Santos RL, Keestra AM, Adams LG, Bäumler AJ. 2002. Salmonella enterica serotype Typhimurium ShdA is an outer membrane fibronectin-binding protein that is expressed in the intestine. Mol Microbiol 43: 895-905.
63. Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, Gordon MA, Harris D, Clarke L, Whitehead S, Sangal V, et al. 2009. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19: 2279-2287.
64. Kingsley RA, Kay S, Connor T, Barquist L, Salt L, Holt KE, Sivaraman K, Wileman T, Goulding D, Clare S, et al. 2013. Genome and transcriptome adaptation accompanying emergence of the definitive type 2 host-restricted Salmonella enterica serovar Typhimurium pathovar. mBio 4: e00565.
65. Kirchner JW, Roy BA. 2002. Evolutionary implications of host-pathogen specificity: Fitness consequences of pathogen virulence traits. Evol Ecol Res 4: 27-48.
66. Kisiela DI, Chattopadhyay S, Libby SJ, Karlinsey JE, Fang FC, Tchesnokova V, Kramer JJ, Beskhlebnaya V, Samadpour M, Grzymajlo K, et al. 2012. Evolution of Salmonella enterica virulence via point mutations in the fimbrial adhesin. PLoS Pathog 8: e1002733.
67. Kothapalli S, Nair S, Alokam S, Pang T, Khakhria R, Woodward D, Johnson W, Stocker BA, Sanderson KE, Liu SL. 2005. Diversity of genome structure in Salmonella enterica serovar Typhi populations. J Bacteriol 187: 2638-2650.
68. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, Monack DM. 2008. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 76: 403-416.
69. Leavitt JW. 1992. "Typhoid Mary" strikes back. Bacteriological theory and practice in early twentieth-century public health. Isis 83: 608-629.
70. Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B, Cossart P. 1999. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 18: 3956-3963.
71. Lecuit M, Vandormael-Pournin S, Lefort J, Huerre M, Gounon P, Dupuy C, Babinet C, Cossart P. 2001. A transgenic model for listeriosis: Role of internalin in crossing the intestinal barrier. Science 292: 1722-1725.
72. Lecuit M, Nelson DM, Smith SD, Khun H, Huerre M, Vacher-Lavenu MC, Gordon JI, Cossart P. 2004. Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: Role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci 101: 6152-6157.
73. null mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci 107: 15589-15594.
74. Liu SL, Sanderson KE. 1995. Rearrangements in the genome of the bacterium Salmonella typhi. Proc Natl Acad Sci 92: 1018-1022.
75. Liu SL, Sanderson KE. 1996. Highly plastic chromosomal organization in Salmonella typhi. Proc Natl Acad Sci 93: 10303-10308.
76. Liu SL, Sanderson KE. 1998. Homologous recombination between rrn operons rearranges the chromosome in hostspecialized species of Salmonella. FEMS Microbiol Lett 164: 275-281.
77. Liu WQ, Liu GR, Li JQ, Xu GM, Qi D, He XY, Deng J, Zhang FM, Johnston RN, Liu SL. 2007. Diverse genome structures of Salmonella paratyphi C. BMC Genomics 8: 290.
78. Liu WQ, Feng Y, Wang Y, Zou QH, Chen F, Guo JT, Peng YH, Jin Y, Li YG, Hu SN, et al. 2009. Salmonella paratyphi C: Genetic divergence from Salmonella choleraesuis and pathogenic convergence with Salmonella typhi. PLoS ONE 4: e4510.
79. LoGiudice K, Ostfield RS, Schmidt KA, Keesing F. 2003. The ecology of infectious disease: Effects of host diversity and community composition on Lyme disease risk. Proc Natl Acad Sci 100: 567-571.
80. Mallory FB. 1898. A histological study of typhoid fever. J Exp Med 3: 611-638.
81. Manz MG. 2007. Human-hemato-lymphoid-system mice: Opportunities and challenges. Immunity 26: 537-541.
82. Mastroeni P, Harrison JA, Chabalgoity JA, Hormaeche CE. 1996. Effect of interleukin 12 neutralization on host resistance and g interferon production in mouse typhoid. Infect Immun 64: 189-196.
83. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE, Dougan G. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192: 237-248.
84. Mathur R, Oh H, Zhang D, Park SG, Seo J, Koblansky A, Hayden MS, Ghosh S. 2012. A mouse model of Salmonella Typhi infection. Cell 151: 590-602.
85. Matthews TD, Edwards R, Maloy S. 2010. Chromosomal rearrangements formed by rrn recombination do not improve replichore balance in host-specific Salmonella enterica serovars. PLoS ONE 5: e13503.
86. Maupin GO, Gage KL, Piesman J, Montenieri J, Sviat SL, VanderZanden L, Happ CM, Dolan M, Johnson BJ. 1994. Discovery of an enzootic cycle of Borrelia burgdorferi in Neotoma mexicana and Ixodes spinipalpis from northern Colorado, an area where Lyme disease is nonendemic. J Infect Dis 170: 636-643.
87. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, et al. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413: 852-856.
88. McClelland M, Sanderson KE, Clifton SW, Latreille P, Porwollik S, Sabo A, Meyer R, Bieri T, Ozersky P, McLellan M, et al. 2004. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 36: 1268-1274.
89. McFadden G. 2005. Poxvirus tropism. Nat Rev Microbiol 3: 201-213.
90. Melican K, Michea Veloso P, Martin T, Bruneval P, Duménil G. 2013. Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model. PLoS Pathog 9: e1003139.
91. Miller A. 1968. The price: A play. Secker and Warburg, London.
92. Miller MR, White A, Boots M. 2005. The evolution of host resistance: Tolerance and control as distinct strategies. J Theor Biol 236: 198-207.
93. Mims CA. 1975. The meaning of persistent infections in nature. Bull World Health Org 52: 745.
94. Morris C, Tam CK, Wallis TS, Jones PW, Hackett J. 2003. Salmonella enterica serovar Dublin strains, which are Vi antigen-positive use type IVB pili for bacterial self-association and human intestinal cell entry. Microb Pathog 35: 279-284.
95. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259.
96. Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, Visintin A, Monks B, Madico G, Rice PA. 2008. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol 180: 3426-3435.
97. Nielsen LR, Schukken YH, Grohn YT, Ersboll AK. 2004. Salmonella Dublin infection in dairy cattle: Risk factors for becoming a carrier. Prev Vet Med 65: 47-62.
98. Ochman H, Soncini FC, Solomon F, Groisman EA. 1996. Identification of a pathogenicity island for Salmonella survival in host cells. Proc Natl Acad Sci 93: 7800-7804.
99. Olsen SJ, Bleasdale SC, Magnano AR, Landrigan C, Holland BH, Tauxe RV, Mintz ED, Luby S. 2003. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol Infect 130: 13-21.
100. Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT. 2002. Genetics, cytokines and human infectious disease: Lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 32: 97-105.
101. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, Churcher C, Mungall KL, Bentley SD, Holden MT, et al. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413: 848-852.
102. Pascopella L, Raupach B, Ghori N, Monack D, Falkow S, Small PL. 1995. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect Immun 63: 4329-4335.
103. Paulin SM, Watson PR, Benmore AR, Stevens MP, Jones PW, Villarreal-Ramos B, Wallis TS. 2002. Analysis of Salmonella enterica serotype-host specificity in calves: Avirulence of S. enterica serotype gallinarum correlates with bacterial dissemination from mesenteric lymph nodes and persistence in vivo. Infect Immun 70: 6788-6797.
104. Pfennig KS. 2001. Evolution of pathogen virulence: The role of variation in host phenotype. Proc Biol Sci 268: 755-760.
105. Phalipon A, Sansonetti PJ. 2007. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: A tool box for survival? Immunol Cell Biol 85: 119-129.
106. Pickard D, Wain J, Baker S, Line A, Chohan S, Fookes M, Barron A, Gaora PO, Chabalgoity JA, Thanky N, et al. 2003. Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol 185: 5055-5065.
107. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH. 1998. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393: 79-82.
108. Porter SB, Curtiss RR. 1997. Effect of inv mutations on Salmonella virulence and colonization in 1-day-old White Leghorn chicks. Avian Dis 41: 45-57.
109. Putnam P. 1927. The trend of typhoid fever mortality in the United States. Am J Hyg 7: 762-781.
110. Rabsch W, Andrews HL, Kingsley RA, Prager R, Tschape H, Adams LG, Bäumler AJ. 2002. Salmonella enterica serotype Typhimurium and its host-adapted variants. Infect Immun 70: 2249-2255.
111. Raffatellu M, Chessa D, Wilson RP, Dusold R, Rubino S, Bäumler AJ. 2005. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect Immun 73: 3367-3374.
112. Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, Lawhon SD, Chu H, Lau T, Bevins CL, et al. 2007. The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun 75: 4342-4350.
113. Rebollo JE, Francois V, Louarn JM. 1988. Detection and possible role of two large nondivisible zones on the Escherichia coli chromosome. Proc Natl Acad Sci 85: 9391-9395.
114. Renauld-Mongenie G, Poncet D, von Olleschik-Elbheim L, Cournez T, Mignon M, Schmidt MA, Quentin-Millet MJ. 1997. Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B. J Bacteriol 179: 6400-6407.
115. Riley M, Anilionis A. 1978. Evolution of the bacterial genome. Ann Rev Microbiol 32: 519-560.
116. Robins-Browne RM, Tokhi AM, Adams LM, Bennett-Wood V. 1994. Host specificity of enteropathogenic Escherichia coli from rabbits: Lack of correlation between adherence in vitro and pathogenicity for laboratory animals. Infect Immun 62: 3329-3336.
117. Roof DM, Roth JR. 1988. Ethanolamine utilization in Salmonella typhimurium. J Bacteriol 170: 3855-3863.
118. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, Le TA, Acosta CJ, Farrar J, Dougan G, et al. 2006. Evolutionary history of Salmonella typhi. Science 314: 1301-1304.
119. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Bäumler AJ. 2001. Animal models of Salmonella infections: Enteritis vs. typhoid fever. Microb Infect 3: 1335-1344.
120. Santos RL, Raffatellu M, Bevins CL, Adams LG, Tukel C, Tsolis RM, Baumler AJ. 2009. Life in the inflamed intestine, Salmonella style. Trends Microbiol 17: 498-506.
121. Saphra I, Winter JW. 1957. Clinical manifestations of salmonellosis in man-An evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 256: 1128-1134.
122. Sato K, Misawa N, Nie C, Satou Y, Iwakiri D, Matsuoka M, Takahashi R, Kuzushima K, Ito M, Takada K, et al. 2011. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 117: 5663-5673.
123. Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, Tang CM. 2006. Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176: 7566-7575.
124. Schneider MC, Prosser BE, Caesar JJE, Kugelberg E, Li S, Zhang Q, Quoraishi S, Lovett JE, Deane JE, Sim RB, et al. 2009. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-899.
125. Schryvers AB, Stojiljkovic I. 1999. Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 32: 1117-1123.
126. Schwan WR, Huang XZ, Hu L, Kopecko DJ. 2000. Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages. Infect Immun 68: 1005-1013.
127. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. 2006. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci 103: 5526-5530.
128. Sebbane F, Jarrett C, Gardner D, Long D, Hinnebusch BJ. 2009. The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect Immun 77: 1222-1229.
129. Selander RK, Beltran P, Smith NH, Helmuth R, Rubin FA, Kopecko DJ, Ferris K, Tall BD, Cravioto A, Musser JM. 1990. Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun 58: 2262-2275.
130. Shivaprasad HL. 2000. Fowl typhoid and pullorum disease. Rev Sci Tech 19: 405-424.
131. Shultz LD, Ishikawa F, Greiner DL. 2007. Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130.
132. Smith MS, Goldman DC, Bailey AS, Pfaffle DL, Kreklywich CN, Spencer DB, Othieno FA, Streblow DN, Garcia JV, Fleming WH, et al. 2010. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8: 284-291.
133. Sojka WJ, Wray C, Shreeve J, Benson AJ. 1977. Incidence of Salmonella infection in animals in England and Wales 1968-1974. J Hyg 78: 43-56.
134. Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG, Flavell RA, Galan JE. 2010. A mouse model for the human pathogen Salmonella Typhi. Cell Host Microbe 8: 369-376.
135. Spanò S, Galán JE. 2012. A Rab32-dependent pathway contributes to Salmonella Typhi host restriction. Science 338: 960-963.
136. Spanò S, Ugalde JE, Galán JE. 2008. Delivery of a Salmonella Typhi exotoxin from a host intracellular compartment. Cell Host Microbe 3: 30-38.
137. Suar M, Jantsch J, Hapfelmeier S, Kremer M, Stallmach T, Barrow PA, Hardt WD. 2006. Virulence of broadand narrow-host-range Salmonella enterica serovars in the streptomycin-pretreated mouse model. Infect Immun 74: 632-644.
138. Sulakvelidze A. 2000. Yersiniae other than Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis: The ignored species. Microbes Infect 2: 297-513.
139. Sun H, Ringdahl U, Homeister JW, Fay WP, Engelberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305: 1283-1286.
140. Taylor LH, Latham SM, Woolhouse ME. 2001. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356: 983-989.
141. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, Sterzenbach T, Tsolis RM, Roth JR, Bäumler AJ. 2011. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci 108: 17480-17485.
142. Thomson NR, Clayton DJ, Windhorst D, Vernikos G, Davidson S, Churcher C, Quail MA, Stevens M, Jones MA, Watson M, et al. 2008. Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Res 18: 1624-1637.
143. Threlfall EJ, Hall ML, Rowe B. 1992. Salmonella bacteraemia in England and Wales, 1981-1990. J Clin Pathol 45: 34-36.
144. Townsend SM, Kramer NE, Edwards R, Baker S, Hamlin N, Simmonds M, Stevens K, Maloy S, Parkhill J, Dougan G, et al. 2001. Salmonella enterica serotype Typhi possesses a unique repertoire of fimbrial gene sequences. Infect Immun 69: 2894-2901.
145. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
146. Tsolis RM, Adams LG, Ficht TA, Bäumler AJ. 1999. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect Immun 67: 4879-4885.
147. Tsui IS, Yip CM, Hackett J, Morris C. 2003. The type IVB pili of Salmonella enterica serovar Typhi bind to the cystic fibrosis transmembrane conductance regulator. Infect Immun 71: 6049-6050.
148. van de Vosse E, Ali S, de Visser AW, Surjadi C, Widjaja S, Vollaard AM, van Dissel JT. 2005. Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR). Hum Genet 118: 138-140.
149. Vayssier-Taussat M, Le Rhun D, Deng HK, Biville F, Cescau S, Danchin A, Marignac G, Lenaour E, Boulouis HJ, Mavris M, et al. 2010. The Trw type IV secretion system of Bartonella mediates host-specific adhesion to erythrocytes. PLoS Pathog 6: e1000946.
150. Virlogeux I, Waxin H, Ecobichon C, Popoff MY. 1995. Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. Microbiology 141: 3039-3047.
151. Vladoianu IR, Chang HR, Pechere JC. 1990. Expression of host resistance to Salmonella typhi and Salmonella typhimurium: Bacterial survival within macrophages of murine and human origin. Microb Pathog 8: 83-90.
152. Voges M, Bachmann V, Kammerer R, Gophna U, Hauck CR. 2010. CEACAM1 recognition by bacterial pathogens is species specific. BMC Microbiol 10: 117.
153. Watson PR, Paulin SM, Bland AP, Jones PW, Wallis TS. 1995. Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect Immun 63: 2743-2754.
154. Watson PR, Galyov EE, Paulin SM, Jones PW, Wallis TS. 1998. Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. Infect Immun 66: 1432-1438.
155. Weening EH, Barker JD, Laarakker MC, Humphries AD, Tsolis RM, Bäumler AJ. 2005. The Salmonella enteric serotype Typhimurium lpf, bcf, stb, stc, std, and sth fimbrial operons are required for intestinal persistence in mice. Infect Immun 73: 3358-3366.
156. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Bäumler AJ. 2008. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 10: 876-890.
157. Winkelstein JA, Marino MC, Johnston RBJ, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169.
158. Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, Russmann H, Bäumler AJ. 2009. The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol Microbiol 74: 175-193.
159. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, et al. 2010a. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426-429.
160. Winter SE, Winter MG, Godinez I, Yang H-J, Russmann H, Andrews-Polymenis HL, Bäumler AJ. 2010b. A rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella. PLoS Pathog 6: e1001060.
161. Woolhouse ME, Taylor LH, Haydon DT. 2001. Population biology of multihost pathogens. Science 292: 1109-1112.
162. Wu KY, Liu GR, Liu WQ, Wang AQ, Zhan S, Sanderson KE, Johnston RN, Liu SL. 2005. The genome of Salmonella enterica serovar Gallinarum: Distinct insertions/deletions and rare rearrangements. J Bacteriol 187: 4720-4727.
163. Xu T, Maloy S, McGuire KL. 2009. Macrophages influence Salmonella host-specificity in vivo. Microb Pathog 47: 212-222.
164. Zahrt TC. 1998. "A genetic analysis of the Salmonella typhi host range". PhD thesis, University of Illinois, Urbana-Champaign.
165. Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, Guillou F, Alonso JM, Taha MK. 2007. Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun 75: 5609-5614.
166. Zeisel MB, Da Costa D, Baumert TF. 2011. Opening the door for hepatitis C virus infection in genetically humanized mice. Hepatology 54: 1873-1875.